ArticleCureus2026
Prevalence and Early Left Ventricular Outcomes of Occlusive Myocardial Infarction in Non-ST-Elevation Acute Coronary Syndrome: A Retrospective Observational Study.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveAcute coronary syndromes are classified by the electrocardiogram (ECG) into ST-elevation myocardial infarction (STEMI) and non-ST-elevation types. However, many patients with non-ST-elevation acute coronary syndrome (NSTE-ACS) have a fully blocked culprit artery, a condition called occlusive myocardial infarction (OMI). We aimed to find how common OMI is in an Indian NSTE-ACS cohort and to compare its early effects on heart function and survival with non-occlusive myocardial infarction (NOMI).
methodsIn this retrospective observational study, 340 patients presenting within 24 hours of chest pain with NSTE-ACS who underwent coronary angiography at a tertiary cardiac centre were enrolled. OMI was defined angiographically as a totally or near-totally occluded culprit artery (Thrombolysis in Myocardial Infarction (TIMI) flow grade 0-1) and NOMI as grade 2-3. Left ventricular ejection fraction (LVEF) was measured at baseline and at three months, and all-cause death was recorded at 9-12 months. Logistic regression identified factors independently associated with OMI.
resultsOMI was found in 112 of 340 patients (32.9%, 95% confidence interval (CI) 28.2-38.1%) and NOMI in 228 (67.1%). The two groups had similar baseline features and risk factors, but non-ST-elevation myocardial infarction (NSTEMI) was more common in the OMI group (83/112 (74.1%) vs. 140/228 (61.4%); p=0.028). OMI patients had a lower baseline LVEF (44.1 ± 11.4% vs. 49.2 ± 11.1%; p<0.001), which stayed lower at three months (50.4 ± 8.3% vs. 53.4 ± 8.5%; p=0.010) despite improvement in both groups. On regression, a lower baseline LVEF was the factor most strongly associated with OMI. Death rates were similar (1/88 (1.1%) vs. 6/175 (3.4%); p=0.49).
conclusionsAbout one in three NSTE-ACS patients undergoing coronary angiography in this single-centre, retrospective cohort had a blocked culprit artery, and this group had worse heart function at presentation and at three months despite similar baseline risk profiles. Given the retrospective, single-centre design and incomplete follow-up, these findings are hypothesis-generating: they support maintaining a high index of suspicion for a blocked artery in NSTE-ACS patients with reduced LVEF, but do not establish that earlier angiography improves outcomes in this subgroup.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.